IFNB1 and myeloid sarcoma: Attenuated responses of DCs, particularly myeloid DCs, to IL-7 or TSLP in the presence of IFNβ, such as during microbial infection, central nervous system inflammation or in the thymus, may contribute to increased MS risk in Hap 4 homozygotes.